Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cellular membranes, including the plasma membrane and the membranes of intracellular organelles such as lysosomes and neutrophil granules, are complex lipid bilayers that define cellular boundaries and compartmentalize biochemical processes. These membranes play a pivotal role in the immune response, particularly in neutrophils, where they sequester potent hydrolytic enzymes and antimicrobial peptides within granules to prevent self-digestion of the host cell (Nathan, 2006). In various inflammatory and autoimmune diseases, the unintended rupture or degranulation of these compartments leads to the release of these enzymes into the extracellular space, causing significant tissue damage (Weissmann, 1969). Pharmacological intervention often involves the use of membrane-stabilizing agents, such as glucocorticoids and lysosomotropic drugs like hydroxychloroquine, which increase the stability of these lipid bilayers and prevent the release of inflammatory mediators (Mauthe et al., 2018). By maintaining the integrity of lysosomal and granule membranes, these drugs mitigate the severity of the inflammatory cascade. However, because these membranes are fundamental to all cells, therapeutic targeting must be carefully managed to avoid systemic toxicity or the disruption of essential endocytic and autophagic pathways (StatPearls, 2023). Consequently, these structures are considered broad therapeutic targets in the management of conditions like rheumatoid arthritis and systemic lupus erythematosus.
Stabilization of lipid bilayers to prevent the release of cytotoxic enzymes and inflammatory mediators from intracellular compartments.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular and lysosomal membranes.